Annaleah L. Eliason

Anesthesiology
30 S Mario Capecchi Dr Rm 5N101
Salt Lake City, UT 84112

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma.

Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma.

Journal: Journal for immunotherapy of cancer
Published: December 18, 2023
Showing 1-1 of 1

Last Updated: 09/26/2026